Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Awards
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
    • Women in Healthcare
    • - Luminaries
    • - Top 25 Diversity Leaders
    • - Leaders to Watch
    • - Luminaries
    • - Top 25 Women Leaders
    • - Women to Watch
  • Events
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Custom Media Event: ESG Summit
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Leadership Symposium
    • Health Care Hall of Fame Gala
    • Top 25 Women Leaders Gala
    • Best Places to Work Awards Gala
    • Top 25 Diversity Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Strategic Marketing
    • - Virtual Health
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Government
July 20, 2016 01:00 AM

Jury acquits medical-device company execs of felony fraud charges

Lisa Schencker
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    A federal jury on Wednesday acquitted two former medical-device company executives on more than a dozen felony counts of fraud related to off-label marketing but convicted them of 10 misdemeanor counts on the same issue.

    The mixed verdict came less than a year after U.S. Deputy Attorney Sally Quillian Yates issued a memo indicating that the Justice Department was committed to holding individuals, not just companies, accountable for corporate misconduct. It's the second recent case in which healthcare executives escaped serious consequences for alleged corporate misconduct.

    The Boston jury convicted former Acclarent CEO William Facteau and former Acclarent Vice President of Sales Patrick Fabian of 10 counts of introducing adulterated and misbranded medical devices into interstate commerce Wednesday, according to the U.S. Attorney's Office for the District of Massachusetts. The trial lasted six weeks.

    Fabian's attorney, Frank Libby, praised the jury's acquittal Wednesday.

    “After a five-year investigation and six-week trial, the jury flatly rejected the government's core fraud and conspiracy theories and what was left are these misdemeanor counts, which required no finding of criminal intent,” said Libby, with the law firm LibbyHoopes in Boston.

    He added that the misdemeanor convictions will face serious scrutiny during post-trial motions and in appeals court, if need be. Libby said healthcare industry leaders should be concerned about those misdemeanor convictions.

    “They should be following this with some care and concern, frankly because the government doesn't have to show wrongful intent, doesn't even have to show the executive was even aware of the conduct in order to pin a misdemeanor conviction on them,” Libby said.

    Libby said the indictment against his client predated the Yates memo, but was in line with the Department of Justice's increased efforts to go after individual executives.

    An attempt to reach Facteau's lawyers was not immediately successful Wednesday afternoon.

    The jury found that the pair caused the illegal distribution of a medical device known as the Relieva Stratus Microflow Spacer for uses not approved by the Food and Drug Administration. The company told the FDA that the device was meant to maintain an opening to a patient's sinus, but then released the product to be used as a steroid delivery device, according to the U.S. Attorney's Office.

    The scheme was part of Facteau and Fabian's strategy to rapidly develop and market products to create a projected revenue stream that would make Acclarent attractive to potential buyers or investors during an initial public offering, according to the U.S. Attorney's Office. Johnson & Johnson subsidiary Ethicon bought Acclarent in 2010.

    The maximum penalty for each count of violating the Food, Drug and Cosmetics Act is a year in prison, a year of supervised release and a fine of $100,000 or twice the money made or lost.

    The verdict Wednesday followed another recent jury verdict in a case against the former president of drug company Warner Chilcott. In June, a federal jury, also in Boston, found W. Carl Reichel not guilty of conspiring with members of Warner Chilcott's sales force to pay kickbacks to doctors in exchange for writing prescriptions. In that case, the government had alleged that Reichel urged sales people to take doctors out to so-called medical education dinners that were actually social events and pay doctors to speak if they prescribed the company's drugs.

    As a company, Warner Chilcott agreed in October to plead guilty to healthcare fraud and pay the government $125 million to settle civil and criminal allegations.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Dr. Anthony Fauci
    Fauci: 'Pandemic phase' over for US, but COVID-19 still here
    greenhouse emission
    5 takeaways from HHS' environmental justice strategy
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Nominate/Eligibility
      • 100 Most Influential People
      • 50 Most Influential Clinical Executives
      • Best Places to Work in Healthcare
      • Excellence in Governance
      • Health Care Hall of Fame
      • Healthcare Marketing Impact Awards
      • Top 25 Emerging Leaders
      • Top 25 Innovators
      • Diversity in Healthcare
        • - Luminaries
        • - Top 25 Diversity Leaders
        • - Leaders to Watch
      • Women in Healthcare
        • - Luminaries
        • - Top 25 Women Leaders
        • - Women to Watch
    • Events
      • Conferences
        • Transformation Summit
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Leadership Symposium
      • Galas
        • Health Care Hall of Fame Gala
        • Top 25 Women Leaders Gala
        • Best Places to Work Awards Gala
        • Top 25 Diversity Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Strategic Marketing
        • - Virtual Health
      • Webinars
      • Custom Media Event: ESG Summit
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing